Video Documentary On PharmaCyte Biotech's Pancreatic Cancer Treatment

Sep. 07, 2019 2:03 PM ETPharmaCyte Biotech, Inc. (PMCB)
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2018

     Stock Market Media Group has shaped and produced a wide range of content, including articles, videos, reports and interviews for hundreds of companies from the biotech, cannabis and technology industries to gaming, mining, and energy. In the U.S., our clients trade on NASDAQ, NYSE, and OTC, while globally clients are listed on both the TSX and CSE in Canada, NASDAQ in Stockholm, and the FSE in Frankfurt.


     As a news and media content development & marketing IR firm, we deliver hundreds of corporate stories every year to financial media outlets worldwide. Our published content is disseminated to all brokerage firms, NASDAQ, OTC, and splashed across such media outlets as The Wall Street Journal, Bloomberg, Yahoo! Finance, MarketWatch, USA Today, CNN, CNBC, and more.


     Our aim is to educate both current and potential shareholders by employing a myriad of content. With thousands of companies vying for the market’s attention, it’s imperative that CEOs use every tool at their disposal to land their company’s story in front of investors. Stock Market Media prides itself on being just that, a resource that executives can utilize to speak directly to the investment community.

Summary

  • A closer look at this hard-to-treat disease and the dreadful statistics.
  • Learn more about the current options available for patients and then we introduce PharmaCyte's signature live-cell encapsulation technology, Cell-in-a-Box.
  • Go inside the body with animations that explain exactly how PharmaCyte's treatment works.

Watch the story of PharmaCyte Biotech's pancreatic cancer therapy unfold in this beautifully told documentary. The video introduces us to this hard-to-treat disease, explains the current options available to pancreatic cancer patients, and then it brings to life PharmaCyte's treatment for locally advanced pancreatic cancer, all while presenting both an emotional and powerful story.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Additional disclosure: Stock Market Media Group (SMMG) has been and expects to continue to be compensated from time to time for writing and publishing articles, research reports, conducting interviews and producing videos with company officials and about the company. SMMG writes extensively about PharmaCyte, and for those published articles, reports, interviews, and videos, SMMG is compensated by third parties, who may own shares in the company and may be selling those shares at the time of our publications. SMMG expects to continue to be compensated from time to time for its research, writing and the production of interviews and videos and the dissemination of that work.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.